Shaun G. Goodman

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry

Ashish Patel, Shaun G. Goodman, Andrew T. Yan et al. · Journal of the American Heart Association · 2018 · 88 citations · Full text

Medicine, Cardiology, Geriatric Medicine +17

Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease

Anish Badjatiya, Peter Merrill, John B. Buse et al. · Circulation Cardiovascular Interventions · 2019 · 66 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy

Marc Cohen, Sandra S. Stinnett, Beth Davison Weatherley et al. · American Heart Journal · 2000 · 36 citations

Medicine, Cardiology, Clinical Sciences +16

Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes

Bradley Sarak, Subodh Verma, C. David Mazer et al. · Cardiovascular Diabetology · 2021 · 32 citations · Full text

Medicine, Cardiology, Pharmacology +17